Revacept in Symptomatic Carotid Stenosis

Clinical trial NCT01645306 · COMPLETED

Trial details

NCT number: NCT01645306
Sponsor: AdvanceCor GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carotid Stenosis Atherosclerosis Stroke Transient-ischaemic Attack TIA Amaurosis Fugax

Start date: 2013-03-08
Primary completion: 2018-10-05
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.